insights_auto
Pse është ulur CRSP 5,67%?
Zhytu më thellëchevron_right
CRSP:NASDAQ
Crispr Therapeutics AG
48,84 US$
arrow_downward
-5,67%(-2,94) 1D
5 nën, 2:55:28 m.d., GMT-5 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për CRSP...
Hap
51,01 US$
I lartë
51,21 US$
I ulët
47,76 US$
Kapitalizimi i tregut
4,73 mld
Vëllimi mesatar
1,44 mln
Vëllimi
1,23 mln
Maksimumi 52-javor
63,45 US$
Minimumi 52-javor
44,12 US$
Fitimet për aksion
-4,75 US$
Beta
1,49
Aksionet në qarkullim
97,00 mln
Numri i punonjësve
393
Hap
51,01 US$
I lartë
51,21 US$
I ulët
47,76 US$
Kapitalizimi i tregut
4,73 mld
Vëllimi mesatar
1,44 mln
Vëllimi
1,23 mln
Maksimumi 52-javor
63,45 US$
Minimumi 52-javor
44,12 US$
Fitimet për aksion
-4,75 US$
Beta
1,49
Aksionet në qarkullim
97,00 mln
Numri i punonjësve
393
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
The Globe and Mail
·
15 orë më parë
Crispr Therapeutics AG (CRSP) Receives a Hold from RBC Capital
Zacks
·
2 ditë më parë
CRSP's Q3 Loss Wider Than Expected, Sales Beat Estimates
Zacks
·
2 ditë më parë
VRTX's Q3 Earnings Lag Estimates, Revenues Top, 2026 Sales View Raised
Yahoo Finance
·
2 ditë më parë
CRSP's Q3 Loss Wider Than Expected, Sales Beat Estimates
Profili
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in the United States. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland; Boston, Massachusetts; San Francisco, California; and London, United Kingdom. Its manufacturing facility in Framingham, Massachusetts, won the Facilities of the Year Award award in 2022. The company’s lead program, exagamglogene autotemcel, or exa-cel, was granted regulatory approval by the US Food and Drug Administration in December 2023. Wikipedia
Rreth Crispr Therapeutics AG
Drejtori ekzekutivSamarth Kulkarni
Punonjësit393
Themeluar më2013
SeliaZug, Kantoni Zug, Zvicër
SektoriHealth Care
Industry-
Uebsajticrisprtx.com